Raymond James & Associates’s Sharps Compliance Corp SMED Stock Holding History

Raymond James & Associates’s Portfolio SMED Stock Details SMED Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell
2022 Q1	$698K	Buy
2021 Q4	$842K	Buy